OTC Markets OTCPK - Delayed Quote USD

Ligand Pharmaceuticals Incorporated (LGNZZ)

0.1200
0.0000
(0.00%)
At close: May 9 at 12:48:03 PM EDT

Research Analysis

Revenue vs. Earnings

Revenue 45.33M
Earnings 26.6M

Q2'24

Q3'24

Q4'24

Q1'25

0
10M
20M
30M
40M
50M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 8887
Avg. Estimate 43.87M49.62M194.02M230.63M
Low Estimate 38.07M44.35M185.13M213.06M
High Estimate 48.29M53.7M199.8M243.1M
Year Ago Sales 41.53M51.81M167.13M194.02M
Sales Growth (year/est) 5.62%-4.24%16.09%18.87%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
LGNZZ --------
S&P 500 13.30%2.58%7.71%13.75%